156 related articles for article (PubMed ID: 27434195)
1. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
[TBL] [Abstract][Full Text] [Related]
2. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
4. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
7. Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9: a case report and review of literature.
Choi WK; Lee DH; Cho DH; Jang KY; Kim KM
BMC Womens Health; 2019 Nov; 19(1):149. PubMed ID: 31775731
[TBL] [Abstract][Full Text] [Related]
8. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
[TBL] [Abstract][Full Text] [Related]
9. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
Kyung MS; Choi JS; Hong SH; Kim HS
Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in mature cystic teratomas of the ovary.
Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
[TBL] [Abstract][Full Text] [Related]
11. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma arising from respiratory ciliated epithelium in mature ovarian cystic teratoma.
Sumi T; Ishiko O; Maeda K; Haba T; Wakasa K; Ogita S
Arch Gynecol Obstet; 2002 Dec; 267(2):107-9. PubMed ID: 12439559
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma arising in a mature cystic teratoma of the ovary in young patient with elevated carbohydrate antigen 19-9.
Arioz DT; Tokyol C; Sahin FK; Koker G; Yilmaz S; Yilmazer M; Ozalp S
Eur J Gynaecol Oncol; 2008; 29(3):282-4. PubMed ID: 18592797
[TBL] [Abstract][Full Text] [Related]
14. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
15. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of mature teratomas containing malignant elements.
Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
[TBL] [Abstract][Full Text] [Related]
17. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.
Cho HY; Kyung MS
Med Sci Monit; 2014 Jul; 20():1334-9. PubMed ID: 25073801
[TBL] [Abstract][Full Text] [Related]
18. Benign teratoma in an 85-year-old woman.
Takahashi K; Shinno T; Watanabe Y; Kurioka H; Miyazaki K
Arch Gynecol Obstet; 2000 Apr; 263(4):188-90. PubMed ID: 10834329
[TBL] [Abstract][Full Text] [Related]
19. Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst.
Yoshida A; Murabayashi N; Shiozaki T; Okugawa T; Tabata T
J Obstet Gynaecol Res; 2005 Oct; 31(5):399-403. PubMed ID: 16176507
[TBL] [Abstract][Full Text] [Related]
20. Relevance of frozen sections and serum markers in invasive squamous cell carcinoma arising from ovarian mature cystic teratoma: two case reports.
Tazo Y; Yoshimura Y; Shoda T; Kyushima N; Okada T; Yamazaki H
J Med Case Rep; 2016 Jan; 10():20. PubMed ID: 26801904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
